Wenzhou Kangning Hospital Co., Ltd. (2120.HK)
HKD 9.13
(0.0%)
HKD 9.13
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.59 Billion | 1.48 Billion | 1.29 Billion | 1.03 Billion | 860.69 Million | 745.97 Million |
| Cost of Revenue | 1.19 Billion | 1.13 Billion | 968.43 Million | 728.7 Million | 656.18 Million | 493.72 Million |
| Gross Profit | 399.3 Million | 352.93 Million | 328.99 Million | 302.58 Million | 204.5 Million | 252.24 Million |
| Operating Expenses | 309.68 Million | 243.91 Million | 206.53 Million | 150.19 Million | 134.23 Million | 99.34 Million |
| Selling, General and Administrative Expenses | 225.46 Million | 74.29 Million | 51.74 Million | 133.13 Million | 131.31 Million | 103.14 Million |
| Research and Development Expenses | 32.46 Million | 33.02 Million | 27.96 Million | 20.97 Million | 6.01 Million | 5.73 Million |
| Other Expenses | 208.66 Million | 136.59 Million | 126.82 Million | -3.91 Million | -3.09 Million | -319.37 Thousand |
| Cost and Expenses | 1.49 Billion | 1.37 Billion | 1.17 Billion | 878.89 Million | 790.42 Million | 593.07 Million |
| Operating Income | 101.45 Million | 101.41 Million | 92.5 Million | 140.95 Million | 73.61 Million | 105.77 Million |
| Interest Expense | 39.93 Million | 45.14 Million | 36.26 Million | 26.55 Million | 26.56 Million | 8.85 Million |
| Income Tax Expense | 12.25 Million | 26.57 Million | 54.83 Million | 28.94 Million | 17.29 Million | 31.94 Million |
| Earnings before Tax | 99.18 Million | 15.6 Million | 95.7 Million | 87.9 Million | 55.52 Million | 106.91 Million |
| Net Income | 85.94 Million | -10.96 Million | 44.03 Million | 55.77 Million | 38.22 Million | 80.59 Million |
| Earnings Per Share Basic | 1.15 | -0.15 | 0.61 | 0.77 | 0.52 | 1.10 |
| Earnings Per Share Diluted | 1.15 | -0.15 | 0.59 | 0.75 | 0.52 | 1.10 |
| Weighted Average Shares Outstanding | 74.6 Million | 74.6 Million | 72.14 Million | 72.45 Million | 73.04 Million | 73.04 Million |
| Weighted Average Shares Outstanding (Diluted) | 74.6 Million | 74.6 Million | 74.6 Million | 73.92 Million | 73.92 Million | 73.04 Million |
| Gross Margin | 0.25 | 0.24 | 0.25 | 0.29 | 0.24 | 0.34 |
| EBIT Margin | 0.16 | 0.15 | 0.16 | 0.22 | 0.17 | 0.24 |
| Profit Margin | 0.05 | -0.01 | 0.03 | 0.05 | 0.04 | 0.11 |
| EBITDA | 252.66 Million | 174.96 Million | 211.31 Million | 189.38 Million | 155.78 Million | 160.11 Million |
| Earnings Before Tax Margin | 0.06 | 0.07 | 0.07 | 0.14 | 0.09 | 0.14 |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Revenue | 1.59 Billion | 409.17 Million | 409.17 Million | 388.96 Million | 388.96 Million | 1.48 Billion |
| Cost of Revenue | 1.18 Billion | 308.65 Million | 308.65 Million | 289.83 Million | 289.83 Million | 1.13 Billion |
| Gross Profit | 411.13 Million | 100.51 Million | 100.51 Million | 99.13 Million | 99.13 Million | 352.93 Million |
| Operating Expenses | 252.52 Million | 71.93 Million | 71.93 Million | 60.78 Million | 60.78 Million | 243.91 Million |
| Selling, General and Administrative Expenses | - | 57.96 Million | 57.96 Million | 54.76 Million | 54.76 Million | - |
| Research and Development Expenses | - | 8.75 Million | 8.75 Million | 7.47 Million | 7.47 Million | - |
| Other Expenses | -2.31 Million | - | - | - | - | 136.59 Million |
| Cost and Expenses | 1.43 Billion | 380.58 Million | 380.58 Million | 350.62 Million | 350.62 Million | 1.37 Billion |
| Operating Income | 101.45 Million | 29.15 Million | 29.15 Million | 38.4 Million | 38.4 Million | 101.41 Million |
| Interest Expense | 39.93 Million | - | - | 21.69 Million | - | 45.14 Million |
| Income Tax Expense | 12.25 Million | 386.06 Thousand | 386.06 Thousand | 5.73 Million | 5.73 Million | 26.57 Million |
| Earnings before Tax | 99.18 Million | 19.48 Million | 19.48 Million | 30.1 Million | 30.1 Million | 15.6 Million |
| Net Income | 85.94 Million | 21.09 Million | 21.09 Million | 21.87 Million | 21.87 Million | -10.96 Million |
| Earnings Per Share Basic | - | 0.28 | 0.28 | 0.29 | 0.29 | - |
| Earnings Per Share Diluted | - | 0.28 | 0.28 | 0.29 | 0.29 | - |
| Weighted Average Shares Outstanding | 74.6 Million | 75.35 Million | 75.35 Million | 74.6 Million | 74.6 Million | 74.6 Million |
| Weighted Average Shares Outstanding (Diluted) | 74.6 Million | 74.6 Million | 74.6 Million | 74.6 Million | 74.6 Million | 74.6 Million |
| Gross Margin | 0.26 | 0.25 | 0.25 | 0.25 | 0.25 | 0.24 |
| EBIT Margin | - | 0.11 | 0.11 | 0.14 | 0.14 | - |
| Profit Margin | 0.05 | 0.05 | 0.05 | 0.06 | 0.06 | -0.01 |
| EBITDA | - | 46.75 Million | 46.75 Million | 56.24 Million | 56.24 Million | - |
| Earnings Before Tax Margin | 0.06 | 0.07 | 0.07 | 0.10 | 0.10 | 0.07 |
GCLL
TAU
600057
RDEB
IREN
CULTIBAB